DWS ESG Biotech TFC
WKN DWS2UA | ISIN DE000DWS2UA1 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | +1,01 % | +18,26 % | -0,07 |
|
| 2 | LU2026682919 | Candriam Equities L Biotech.V2 USD Acc | -1,64 % | +18,08 % | -0,22 |
|
| 3 | LU0942225912 | Candriam Equities L Biotech.R USD Acc | -1,87 % | +18,06 % | -0,23 |
|
| 4 | LU1269736838 | Candriam Equities L Biotech.R EUR Acc | -2,10 % | +18,50 % | -0,24 |
|
| 5 | LU0317020203 | Candriam Equities L Biotechnology, V - Capitalisation | -1,99 % | +17,91 % | -0,24 |
|
| 48 | DE000DWS2UA1 | DWS ESG Biotech TFC | -8,58 % | +19,70 % | -0,55 |
|
| 73 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -7,65 % | +11,89 % | -0,84 |
|
| 74 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -13,82 % | +19,03 % | -0,85 |
|
| 75 | LU0767968745 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | -7,19 % | +10,57 % | -0,90 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -32,79 % | +29,58 % | -1,19 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -32,87 % | +29,56 % | -1,20 |
|